The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy
- 30 June 2008
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 198 (2), 396-402
- https://doi.org/10.1016/j.atherosclerosis.2007.10.026
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Primary Prevention of Cardiovascular Diseases in People With Diabetes MellitusCirculation, 2007
- Dyslipidemia Prevalence, Treatment, and Control in the Multi-Ethnic Study of Atherosclerosis (MESA)Circulation, 2006
- National Study of Women’s Awareness, Preventive Action, and Barriers to Cardiovascular HealthCirculation, 2006
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesThe New England Journal of Medicine, 2005
- Pharmacologic Lipid-Lowering Therapy in Type 2 Diabetes Mellitus: Background Paper for the American College of PhysiciansAnnals of Internal Medicine, 2004
- European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)European Journal of Preventive Cardiology, 2003
- Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2003
- The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)Clinical Science, 2001
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ, 2000
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998